| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |